Structures by: Schmid W. F.
Total: 21
9-Nitro-6-(alpha-picolylamino)-7,12-dihydroindolo[3,2-d][1]benzazepine
C22H17N5O2
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=10.8951(10)Å b=20.050(2)Å c=8.6412(9)Å
α=90.00° β=90.160(4)° γ=90.00°
(hapto^6^-p-Cymene)[9-pyridin-kappaN-2-yl-(E)-methylidene)amino-kappaN-7,12- dihydroindolo[3,2-d][1]benzazepin-6(5H)-one]chloroosmium(II) chloride acetone solvate
C35H36Cl2N4O2Os
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=9.876(2)Å b=9.6263(19)Å c=17.460(4)Å
α=90.00° β=104.32(3)° γ=90.00°
(hapto^6^-p-Cymene){9-nitro-6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chlororuthenium(II) chloride diethanol solvate
C36H43Cl2N5O4Ru
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=12.2485(4)Å b=12.6418(5)Å c=14.3132(5)Å
α=95.421(2)° β=108.122(2)° γ=118.054(2)°
(hapto^6^-p-Cymene){9-nitro-6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chlororuthenium(II) chloride diethanol water solvate
C36H45Cl2N5O5Ru
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=10.771(2)Å b=25.040(5)Å c=13.238(3)Å
α=90.00° β=91.84(3)° γ=90.00°
(hapto^6^-p-Cymene){9-bromo-6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chloroosmium(II) chloride ethanol water solvate
C130H133Br4Cl8N16O3.5Os4
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=13.8319(5)Å b=14.1376(5)Å c=18.3912(6)Å
α=98.511(2)° β=107.338(2)° γ=102.012(2)°
(hapto^6^-p-Cymene){9-nitro-6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chloroosmium(II) chloride ethanol water solvate
C35.9H42.95Cl2N5O4.08Os
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=12.2836(4)Å b=12.6756(4)Å c=14.2592(6)Å
α=95.491(2)° β=107.998(2)° γ=118.072(2)°
(hapto^6^-p-Cymene){6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chloroosmium(II) chloride water solvate
C32H32.5Cl2N4O0.25Os
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=13.9580(7)Å b=14.0949(7)Å c=18.3531(9)Å
α=96.749(3)° β=108.022(3)° γ=102.050(3)°
Cis,cis,cis- dichlorobis(dimethylsulfoxide)bis(indazole)ruthenium(ii)
C18H24Cl2N4O2RuS2
Dalton transactions (Cambridge, England : 2003) (2005) 14 2355-2364
a=12.194(2)Å b=12.888(3)Å c=14.720(3)Å
α=90.00° β=107.68(3)° γ=90.00°
Trans,cis,cis- dichlorobis(dimethylsulfoxide)bis(indazole)ruthenium(ii)
C18H24Cl2N4O2RuS2
Dalton transactions (Cambridge, England : 2003) (2005) 14 2355-2364
a=11.833(2)Å b=13.477(3)Å c=16.340(3)Å
α=113.96(3)° β=97.57(3)° γ=104.00(3)°
Trans,trans,trans- dichlorobis(dimethylsulfoxide)bis(indazole)ruthenium(ii)
C22H36Cl2N4O4RuS4
Dalton transactions (Cambridge, England : 2003) (2005) 14 2355-2364
a=27.0678(5)Å b=7.8991(5)Å c=14.0096(3)Å
α=90.00° β=94.1198(12)° γ=90.00°
Trans-dichlorobis(dimethylsulfoxide)amidineruthenium(ii) monohydrate
C13H23Cl2N3O3RuS2
Dalton transactions (Cambridge, England : 2003) (2005) 14 2355-2364
a=17.726(4)Å b=8.367(2)Å c=14.415(3)Å
α=90.00° β=113.56(3)° γ=90.00°
Trans- dichloro(dimethylsulfoxide)(indazole)amidineruthenium(ii) acetonitrile
C20H24Cl2N6ORuS
Dalton transactions (Cambridge, England : 2003) (2005) 14 2355-2364
a=12.235(2)Å b=14.800(3)Å c=13.614(3)Å
α=90.00° β=105.69(3)° γ=90.00°
(hapto^6^-p-Cymene)[9-pyridin-kappaN-2-yl-(E)-methylidene)amino-kappaN-7,12- dihydroindolo[3,2-d][1]benzazepin-6(5H)-one]chlororuthenium(II) chloride acetone solvate
C35H36Cl2N4O2Ru
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=9.872(2)Å b=9.6208(19)Å c=17.434(4)Å
α=90.00° β=104.05(3)° γ=90.00°
6-(alpha-picolylamino)-7,12-dihydroindolo[3,2-d][1]benzazepine
C22H18N4
Inorganic Chemistry (2007) 46, 3645-3656
a=8.919(2)Å b=19.849(4)Å c=20.229(4)Å
α=90.00° β=90.00° γ=90.00°
9-Bromo-6-(alpha-picolylamino)-7,12-dihydroindolo[3,2-d][1]benzazepine
C22H17BrN4
Inorganic Chemistry (2007) 46, 3645-3656
a=11.0629(5)Å b=19.5840(9)Å c=8.6930(5)Å
α=90.00° β=94.466(3)° γ=90.00°
(OC-6-14)-Dichlorobis(dimethyl sulfoxide)(6-(E)-[alpha-picolyl- kappaN]-7,12-dihydroindolo[3,2-d][1]benzazepine]ruthenium(II) diethanol solvate
C30H42Cl2N4O4RuS2
Inorganic Chemistry (2007) 46, 3645-3656
a=15.366(3)Å b=7.5306(15)Å c=29.650(6)Å
α=90.00° β=104.11(3)° γ=90.00°
(OC-6-43)-Bis(9-bromo-6-(E)-[(alpha-picolyl-kappaN)imino-kappaN]- 7,12-dihydroindolo[3,2-d][1]benzazepine)chloro(dimethyl sulfoxide) ruthenium(II) chloride 2.8ethanol 0.2water
C51.6H55.2Br2Cl2N8O4RuS
Inorganic Chemistry (2007) 46, 3645-3656
a=12.4094(3)Å b=12.8933(3)Å c=18.5633(5)Å
α=106.807(2)° β=92.525(2)° γ=108.003(2)°
N-(9-bromo-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-yliden-N'- 2-hydroxybenzylidene)azinium nitrate methanol solvate
C24H22BrN5O5
Organometallics (2007) 26, 26 6643
a=9.0821(8)Å b=10.9265(9)Å c=12.4005(12)Å
α=71.806(6)° β=76.420(6)° γ=88.703(6)°
(hapto^6^-p-Cymene)[N-(9-bromo-7,12-dihydroindolo[3,2-d][1]benzazepin- kappaN-6-yl)-N'-kappaN-(2-hydroxybenzylidene)azine]chloroosmium(II) chloride ethanol solvate
C35H37BrCl2N4O2Os
Organometallics (2007) 26, 26 6643
a=11.0920(10)Å b=11.1604(8)Å c=13.9373(11)Å
α=90.00° β=90.296(6)° γ=90.00°
(hapto^6^-p-Cymene)[N-(9-bromo-7,12-dihydroindolo[3,2-d][1]benzazepin- kappaN-6-yl)-N'-kappaN-(2-hydroxybenzylidene)azine]chlororuthenium(II) chloride ethanol solvate
C35H37BrCl2N4O2Ru
Organometallics (2007) 26, 26 6643
a=11.0237(9)Å b=11.0373(7)Å c=13.7107(11)Å
α=90.00° β=90.076(6)° γ=90.00°
(hapto^6^-p-Cymene)[N-(9-bromo-7,12-dihydroindolo[3,2-d][1]benzazepin- kappaN-6-yl)-N'-kappaN-(3-hydroxy-5-(hydroxymethyl)-2-methyl-pyridin- 4-yl-methylene)azine]chloroosmium(II) acetone water solvate
C77H88.2Br2Cl4N10O8.1Os2
Organometallics (2007) 26, 26 6643
a=13.1551(7)Å b=16.7459(9)Å c=19.1476(9)Å
α=81.092(3)° β=83.527(3)° γ=72.158(4)°